Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Genmab/AbbVie Lymphoma Trial Meets Main Goal, Analyst Eyes Bigger Market Opportunity
Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial